Post-Traumatic Stress Disorder (PTSD) Market to Register Stunning Growth During the Forecast Period (2022-32) | Acer Therapeutics (ACER-801), Aptinyx (NYX-783), Otsuka, Nobilis, Bionorica

 Breaking News
  • No posts were found

Post-Traumatic Stress Disorder (PTSD) Market to Register Stunning Growth During the Forecast Period (2022-32) | Acer Therapeutics (ACER-801), Aptinyx (NYX-783), Otsuka, Nobilis, Bionorica

October 13
20:10 2022
Post-Traumatic Stress Disorder (PTSD) Market to Register Stunning Growth During the Forecast Period (2022-32) | Acer Therapeutics (ACER-801),  Aptinyx (NYX-783), Otsuka, Nobilis, Bionorica
Delveinsight Business Research LLP
DelveInsight’s “Post-Traumatic Stress Disorder (PTSD) Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Post-Traumatic Stress Disorder Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Post-Traumatic Stress Disorder market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, key drivers & barriers impacting the market growth, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Post-Traumatic Stress Disorder Market

Post-Traumatic Stress Disorder (PTSD): An Overview

Post-traumatic stress disorder (PTSD) is a disorder that develops in some people who have experienced a shocking, scary, or dangerous event. People with PTSD have intense, disturbing thoughts and feelings related to their experience that last long after the traumatic event has ended. They may relive the event through flashbacks or nightmares; they may feel sadness, fear, or anger; and they may feel detached or estranged from other people.

People with PTSD may avoid situations or people that remind them of the traumatic event, and they may have strong negative reactions to something as ordinary as a loud noise or an accidental touch.

The main treatments for people with PTSD are medications, psychotherapy (“talk” therapy), or both. Medications for treating PTSD are antidepressants, which may help control PTSD symptoms such as sadness, worry, anger, and feeling numb inside. Other medications may be helpful for treating specific PTSD symptoms, such as sleep problems and nightmares.

As per DelveInsight, the Post-Traumatic Stress Disorder (PTSD) market size is anticipated to increase in the coming years owing to the rise in the number of prevalent cases in the 7MM and the launch of emerging therapies.

Post-Traumatic Stress Disorder (PTSD) Market Key Fact 

  • As per the study titled “Post‐traumatic stress disorder: a state‐of‐the‐art review of evidence and challenges” conducted by Richard A. Bryant (2019), Epidemiological studies have reported lifetime PTSD prevalence rates of 13.0‐20.4% for women and 6.2‐8.2% for men.

  • PTSD affects approximately 3.5 percent of U.S. adults, and an estimated one in 11 people will be diagnosed with PTSD in their lifetime. 

  • The prevalence of PTSD among adolescents was higher for females (8.0%) than for males (2.3%).

Post-Traumatic Stress Disorder (PTSD) Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Post-Traumatic Stress Disorder market size by analyzing the impact of current and emerging pipeline therapies. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies set to impact the market dynamics.

The report gives complete detail of the Post-Traumatic Stress Disorder market trend for each marketed drug and mid & late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, their Mechanism of Action (MoA), Route of Administration (RoA), molecule types, competition with other therapies, brand value, and their impact on the market.

Post-Traumatic Stress Disorder (PTSD) Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted epidemiology trends by exploring numerous studies and research. The epidemiology section also provides a detailed analysis of diagnosed and prevalent patient pool, future trends, and and views of key opinion leaders. 

Post-Traumatic Stress Disorder (PTSD) Epidemiology Segmentation

  • Prevalent Cases of Post-traumatic stress disorder

  • Age-specific Prevalent Cases of Post-traumatic stress disorder

  • Gender-specific Prevalent Cases of Post-traumatic stress disorder

  • Diagnosed and Treatable Cases of Post-traumatic stress disorder

Post-Traumatic Stress Disorder (PTSD) Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Post-Traumatic Stress Disorder market or expected to get launched during the study period. The analysis covers Post-Traumatic Stress Disorder market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Post-Traumatic Stress Disorder Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Learn How Post-Traumatic Stress Disorder Market Will Evolve by 2032 @

Post-Traumatic Stress Disorder (PTSD) Therapeutics Analysis

The current pipeline for Post-traumatic stress disorder has many significant products. Globally, several key players are developing therapies for the treatment of Post-traumatic stress disorder. The expected launch of emerging therapies is expected to create a positive shift in the market size in the upcoming years.

Some of the key companies in the Post-Traumatic Stress Disorder (PTSD) market include:

  • Aptinyx

  • Otsuka Pharmaceutical

  • Nobilis Therapeutics 

  • Bionorica SE 

And many others 

Post-Traumatic Stress Disorder (PTSD) therapies covered in the report include:

  • NYX-783

  • Brexpiprazole

  • NBTX-001

  • BX-1

  • Mentabinol (Canaquest Medical) 

And other 

Further Emerging Drugs & Key Companies are Covered in the Report. Download the Sample PDF to Learn More:

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Post-Traumatic Stress Disorder Competitive Intelligence Analysis

4. Post-Traumatic Stress Disorder Market Overview at a Glance

5. Post-Traumatic Stress Disorder Disease Background and Overview

6. Post-Traumatic Stress Disorder Patient Journey

7. Post-Traumatic Stress Disorder Epidemiology and Patient Population (In US, EU5, and Japan)

8. Post-Traumatic Stress Disorder Treatment Algorithm, Current Treatment, and Medical Practices

9. Post-Traumatic Stress Disorder Unmet Needs

10. Key Endpoints of Post-Traumatic Stress Disorder Treatment

11. Post-Traumatic Stress Disorder Marketed Products

12. Post-Traumatic Stress Disorder Emerging Drugs and Latest Therapeutic Advances

13. Post-Traumatic Stress Disorder Seven Major Market Analysis

14. Attribute Analysis

15. Post-Traumatic Stress Disorder Market Outlook (In US, EU5, and Japan)

16. Post-Traumatic Stress Disorder Access and Reimbursement Overview

17. KOL Views on the Post-Traumatic Stress Disorder Market

18. Post-Traumatic Stress Disorder Market Drivers

19. Post-Traumatic Stress Disorder Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF to Explore the Key Offerings of the Report:


About DelveInsight

DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

Other Trending Healthcare Reports By DelveInsight

Post-Traumatic Stress Disorder (PTSD) Pipeline Insights

As per DelveInsight’s assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Post-Traumatic Stress Disorder (PTSD) therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States

Related Articles